 Sara Gracie
Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurodevelopmental Disorders | 2 | 2024 | 227 | 1.230 |
Why?
| | Developmental Disabilities | 2 | 2024 | 281 | 0.850 |
Why?
| | Intellectual Disability | 2 | 2023 | 175 | 0.800 |
Why?
| | Bone Diseases, Developmental | 1 | 2022 | 16 | 0.710 |
Why?
| | Abnormalities, Multiple | 1 | 2022 | 197 | 0.630 |
Why?
| | Obstetric Labor, Premature | 2 | 2011 | 39 | 0.420 |
Why?
| | Guidelines as Topic | 1 | 2011 | 268 | 0.300 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2011 | 157 | 0.300 |
Why?
| | Environment | 1 | 2010 | 305 | 0.290 |
Why?
| | Research Design | 2 | 2011 | 1137 | 0.270 |
Why?
| | Premature Birth | 1 | 2010 | 380 | 0.250 |
Why?
| | Proteomics | 2 | 2024 | 1195 | 0.250 |
Why?
| | Phenotype | 3 | 2024 | 3164 | 0.250 |
Why?
| | Fucose | 1 | 2026 | 7 | 0.240 |
Why?
| | Influenza Vaccines | 1 | 2011 | 529 | 0.240 |
Why?
| | Congenital Disorders of Glycosylation | 1 | 2026 | 18 | 0.230 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2026 | 56 | 0.230 |
Why?
| | Dichloroacetic Acid | 1 | 2024 | 7 | 0.220 |
Why?
| | Influenza, Human | 1 | 2011 | 617 | 0.220 |
Why?
| | Acidosis, Lactic | 1 | 2024 | 45 | 0.210 |
Why?
| | Heterozygote | 1 | 2024 | 315 | 0.200 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1786 | 0.200 |
Why?
| | rab GTP-Binding Proteins | 1 | 2023 | 76 | 0.190 |
Why?
| | Vaccination | 1 | 2011 | 1423 | 0.180 |
Why?
| | Truth Disclosure | 1 | 2021 | 50 | 0.170 |
Why?
| | HEK293 Cells | 1 | 2022 | 744 | 0.150 |
Why?
| | Physician-Patient Relations | 1 | 2021 | 588 | 0.120 |
Why?
| | Neurons | 1 | 2024 | 1642 | 0.110 |
Why?
| | Child, Preschool | 3 | 2026 | 11799 | 0.110 |
Why?
| | Humans | 10 | 2026 | 144957 | 0.090 |
Why?
| | Alberta | 1 | 2011 | 26 | 0.080 |
Why?
| | Female | 7 | 2026 | 78376 | 0.080 |
Why?
| | Infant | 1 | 2024 | 10039 | 0.080 |
Why?
| | Cohort Studies | 2 | 2011 | 5965 | 0.080 |
Why?
| | Pregnancy | 3 | 2011 | 7191 | 0.080 |
Why?
| | Canada | 1 | 2010 | 428 | 0.070 |
Why?
| | Clinical Protocols | 1 | 2010 | 282 | 0.070 |
Why?
| | Labor Onset | 1 | 2008 | 2 | 0.070 |
Why?
| | Tocolysis | 1 | 2008 | 4 | 0.070 |
Why?
| | Tocolytic Agents | 1 | 2008 | 16 | 0.070 |
Why?
| | Forecasting | 1 | 2010 | 391 | 0.070 |
Why?
| | Uterine Contraction | 1 | 2008 | 18 | 0.070 |
Why?
| | Drugs, Investigational | 1 | 2008 | 31 | 0.070 |
Why?
| | Drug Design | 1 | 2008 | 173 | 0.070 |
Why?
| | Child | 2 | 2024 | 22657 | 0.070 |
Why?
| | Glycosylation | 1 | 2026 | 172 | 0.060 |
Why?
| | Male | 4 | 2026 | 72406 | 0.060 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2024 | 10 | 0.050 |
Why?
| | Introns | 1 | 2024 | 254 | 0.050 |
Why?
| | Alleles | 1 | 2026 | 881 | 0.050 |
Why?
| | Pandemics | 1 | 2011 | 1695 | 0.040 |
Why?
| | Genetic Association Studies | 1 | 2023 | 373 | 0.040 |
Why?
| | Dietary Supplements | 1 | 2026 | 576 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2023 | 340 | 0.040 |
Why?
| | Prospective Studies | 1 | 2010 | 7997 | 0.030 |
Why?
| | Critical Illness | 1 | 2024 | 892 | 0.030 |
Why?
| | Adolescent | 2 | 2023 | 22453 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2011 | 6053 | 0.030 |
Why?
| | Risk Factors | 1 | 2010 | 10792 | 0.030 |
Why?
| | Communication | 1 | 2021 | 967 | 0.030 |
Why?
| | Biomarkers | 1 | 2026 | 4275 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2024 | 6434 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5872 | 0.020 |
Why?
| | Gestational Age | 1 | 2008 | 975 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2008 | 11695 | 0.010 |
Why?
|
|
Gracie's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|